Abstract
Isolated pancreatic metastases (isPM) are a rare metastasizing pattern in the natural history of renal cell cancer. Their clinical hallmark is that they are confined to a single organ, the pancreas, while all other organs are unaffected for a long time. Almost all workers in the field suggested that mechanical tumor cell propagation to the pancreas may be the mechanism underlying this metastasizing pattern. In 2006 our group, by contrast, proposed an alternative mechanism, i.e. a special affinity of the tumor cells for the pancreas. In the present study an attempt was made to shed more light on the settlement of isPM by reviewing recent literature data. 666 observations of isPM reported in the literature were reviewed. The analyses showed that local lymphatic spread does not play a major role because the lymphatic system is, in general, rarely involved in isPM. This also applies to a local venous spread, because the site of pancreatic metastases is independent of the side affected by the primary renal cancer. But the results are compatible with a systemic metastatic pathway. That metastases in other organs, which would be expected given a systemic spread, are absent can plausibly be explained by a seed and soil mechanism: only the pancreas offers the tumor cell emboli an environment which is conducive to the growth of clinically manifest metastases, while settlement of metastatic tumor cells is prevented in all other organs.
Similar content being viewed by others
References
Sellner F, Tykalsky N, De Santis M, Pont J, Klimpfinger M (2006) Solitary and multiple isolated metastases of clear cell renal carcinoma to the pancreas: an indication for pancreatic surgery. Ann Surg Oncol 13:75–85
Paget S (1989) The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev 8:98–101
Shibue T, Weinberg R (2011) Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment. Semin Cancer Biol 21:99–106
Talmadge J, Fidler I (2010) AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 70:5649–5669
Hedley B, Chambers A (2009) Tumor dormancy and metastasis. Adv Cancer Res 102:67–101
Chambers A, Groom A, MacDonald I (2002) Metastasis: dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572
Chambers A, Varghese H, Nadkarni K, MacDonald I, Groom A (2001) Critical steps in hematogenous metastasis: an overview. Surg Oncol Clin N Am 10:243–255
Hunter K (2004) Host genetics and tumour metastasis. Br J Cancer 90:752–755
Schlüter K, Gassmann P, Enns A, Korb T, Hemping-Bovenkerk A, Hölzen J, Haier J (2006) Organ specific tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential. Am J Pathol 169:1064–1073
Nicolson G (1988) Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 7:143–188
Strell C, Entschladen F (2008) Extravasation of leukocytes in comparison to tumor cells. Cell Commun Signal 6:10. https://doi.org/10.1186/1478-811X-6-10
Miles F, Pruitt F, van Golen K, Cooper C (2008) Stepping out the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis 25:305–324
Zhang Q, Yang M, Shen J, Gerhold M, Hoffman R, Xing H (2010) The role of the intravascular microenvironment in spontaneous metastasis development. Int J Cancer 126:2534–2541
Gandalovičová A, Rosel D, Fernandes M, Veselý P, Heneberg P, Čermák V, Petruželka L, Kumar S, Sanz-Moreno V, Brábek J (2017) Migrastatics—anti-metastatic and anti-invasion drugs: promises and challenges. Trends Cancer 3:391–406
Clark A, Vignjevic D (2015) Modes of cancer cell invasion and the role of the microenvironment. Curr Opin Cell Biol 36:13–22
Friedl P, Wolf K (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3:362–374
Wong M, Sidik S, Mahmud R, Stanslas J (2013) Molecular targets in the discovery and development of novel antimetastatic agents: current progress and future prospects. Clin Exp Pharmacol Physiol 40:307–319
Luzzi K, MacDonald I, Schmidt E, Kerkvliet N, Morris V, Chambers A, Groom AC (1998) Multistep nature of metastatic efficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153:865–873
Naumov G, MacDonald I, Weinmeister P, Kerkvliet N, Nadkarni K, Wilson S, Morris V, Groom A, Chambers A (2002) Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 62:2162–2168
Hynes R (2009) The extracellular matrix: not just pretty fibrils. Science 326:1216–1219
Killion J, Fidler I (1998) Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators. Pharmacol Ther 78:141–54
Fidler I, Gersten D, Hart I (1978) The biology of cancer invasion and metastasis. Adv Cancer Res 28:149–250
Folkman J (2006) Angiogenesis. Annu Rev Med 57:1–18
Gassmann P, Haier J (2008) The tumor cell-host interface in the early onset of metastatic organ colonisation. Clin Exp Metastasis 25:171–181
Tarin D, Price J, Kettlewell M, Souter R, Vass A, Crossley B (1984) Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunt. Cancer Res 44:3584–3592
Jonasch E, Gao J, Rathmell K (2014) Renal cell carcinoma. BMJ 349:g4797
McNichols D, Segura J, DeWeerd J (1981) Renal cell carcinoma: long term survival and late recurrence. J Urol 126:17–23
Schwarz L, Sauvanet A, Regenet N, Mabrut J, Gigot J, Housseau E, Millat B, Ouaissi M, Gayet B, Fuks D, Tuech J (2014) Long-term survival after pancreatic resection for renal cell carcinoma metastasis. Ann Surg Oncol 21:4007–4013
Benhaim R, Oussoultzoglou R, Saeedi E, Mouracade Y, Bachellier P, Lang H (2015) Pancreatic metastasis from clear cell renal cell carcinoma: outcome of an aggressive approach. Urology 85:135–140
Moletta L, Milanetto A, Vincenzi V, Alaggio R, Pedrazzoli S, Pasquali C (2014) Pancreatic secondary lesions from renal cell carcinoma. World J Surg 38:3002–3006
Fikatas P, Klein F, Andreou A, Schmuck R, Pratschke J, Bahra M (2016) Long-term survival after surgical treatment of renal cell carcinoma metastasis within the pancreas. Anticancer Res 36:4273–4278
Motzer R, Hutson T, Tomczak P, Michaelson D, Bukowski R, Oudard ST, Negrier S, Szczlik C, Pili R, Bjarnason G, Garcia-del-Muro X, Sasman J, Solska E, Wilding G, Thompson J, Kim S, Chen I, Huang X, Figlin R (2009) Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cancer. J Clin Oncol 27:3584–3590
Thadani A, Pais SH, Savino J (2011) Metastasis of renal cell carcinoma to the pancreas 13 years postnephrectomy. Gastroenterol Hepatol (NY) 7:697–699
Santoni M, Conti A, Partelli S, Porta C, Sternberg C, Procopio G, Bracarda S, Basso U, De Giorgi U, Derosa L, Rizzo M, Ortega C, Massari F, Iacovelli R, Milella M, Di Lorenzo G, Buti S, Cerbone L, Burattini L, Montironi R, Santini D, Falconi M, Cascinu S (2015) Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors. Ann Surg Oncol 22:2094–2100
Dekernion J, Ramming K, Smith R (1978) The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 120:148–152
Escudier B, Bellmunt J, Negrier S, Bajetta E, Melichar B, Bracarda S, Ravaud A, Golding S, Jethwa S, Sneller V (2010) Phase III trial of Bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (Avoren): final analysis of overall survival. J Clin Oncol 28:2144–2150
Boussios ST, Zerdes I, Batsi O, Papakostas V, Seraj E, Pentheroudakis G, Glantzounis G (2016) Pancreatic resection for renal cell carcinoma: an exceptionally rare coexistence. Int J Surg Case Rep 27:198–201
Schauer M, Vogelsang H, Siewert J (2008) Pancreatic resection for metastatic renal cell carcinoma: a single center experience and review of the literature. Anticancer Res 28:361–366
Miyao M, Naito S, Ozono S, Shinohara N, Masumori N, Igarashi T, Nakao M, Tsushima T, Senga Y, Horie S, Kanayama H, Tokuda N, Kobayashi M (2011) Late recurrence of renal cell carcinoma: retrospective and collaborative study of the japanese society of renal cancer. Urology 77:379–384
Jenssen E (1952) A metastatic hypernephroma to the pancreas. Acta Chir Scand 104:177–180
Bassi C, Butturini G, Falconi M, Sargenti M, Mantovavi W, Pederzoli P (2003) High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma. Br J Surg 90:555–559
Cunzao W, Zhou Z, Ye X, Hu W (2016) Synchronous renal cell carcinoma metastasis to the contralateral adrenal gland and pancreas: a case report with 7 year follow up subsequent to surgical therapy. Oncol Lett 11:4144–4146
Yuasa T, Inoshita N, Saiura A, Yamamoto S, Urakami S, Masuda H, Fujii Y, Fukui I, Ishikawa Y, Yonese J (2015) Clinical outcome of patients with pancreatic metastases from renal cell cancer. BMC Cancer 15:46
Gajendra S, Sachdew R, Mohapatra I, Goel R, Goel S (2015) Metastatic renal cell carcinoma: an unusual cause of bleeding pancreatic mass. J Clin Diagn Res 9:ED15–ED17
Kimura Y, Keira Y, Imamura M, Ito T, Nobuoka T, Mizuguchi T, Masumori N, Hasegawa T, Hirata K (2014) Histopathological aspects of pancreatic metastases in renal cell carcinoma: does the mode of invasion permit limited resections? Pancreat Disord Ther 4:2
Tosoian J, Cameron J, Allaf M, Hruban R, Nahime C, Pawlik T, Pierorazio F, Reddy S, Wolfgang C (2014) Resection of isolated renal cell carcinoma metastases of the pancreas: outcomes from the John Hopkins Hospital. J Gastrointest Surg 18:542–548
Niess H, Conrad C, Kleespies A, Haas F, Bao Q, Jauch KW, Graeb CH, Bruns CH (2013) Surgery for metastasis to the pancreas: is it safe and effective? J Surg Oncol 107:859–864
Hata T, Sakata N, Aoki T, Yoshida H, Kanno A, Fujishima F, Motoi F, Masamune A, Shimosegawa T, Unno M (2013) Repeated pancreatectomy for metachronous duodenal and pancreatic metastases of renal cell carcinoma. Case Rep Gastroenterol 7:442–448
Firek P, Richter S, Jaekel J, Brehmer B, Heidenreich A (2012) Metastasectomy in renal cell cancer after neoadjuvant therapy with multi-tyrosine kinase inhibitors. Urologe 51:398–402
Yazbek TH, Gayet B (2012) The place of enucleation and enucleo-resection in the treatment of pancreatic metastasis of renal cell carcinoma. JOP 13:433–438
Katsourakis A, Noussios G, Hadjis I, Alatsakis M, Chatzitheoklitos E (2012) Late solitary pancreatic metastasis from renal cell carcinoma: a case report. Case Rep Med 2012:464808
Hung J, Wang S, Shyr Y, Su CH, Chen T, Wu CH (2012) Resection for secondary malignancy of the pancreas. Pancreas 41:121–129
You D, Choi D, Choi S, Heo J, Kim W, Ho CH, Lee H (2011) Surgical resection of metastasis to the pancreas. J Korean Surg 80:278–282
D’Ambra M, Ricci C, Casadei R, Minni F (2011) Pancreatic metastasis from renal cell carcinoma. Urologia 78(S18):5–8
Hijioka S, Hifumi M, Mekky M, Takekuma Y, Kawaguchi T, Yokomizo H, Sato T (2010) Total pancreatectomy for metastatic renal cell carcinoma with marked extension into the main pancreatic duct. Inter Med 49:557–562
Konstantinidis I, Dursun A, Zheng H, Wargo J, Thayer S, Castillo C, Warshaw A, Ferrone C (2010) Metastatic tumors in the pancreas in the modern era. J Am Coll Surg 211:749–753
Tanis P, van der Gaag N, Busch O, van Gulik T, Gouma D (2009) Systematic review of pancreatic surgery for metastatic renal cell carcinoma. Br J Surg 96:579–592
Volk A, Kersting ST, Konopke R, Dobrowolski F, Franzen ST, Ockert D, Grützmann R, Saeger H, Bergert H (2009) Surgical therapy of intrapancreatic metastasis from renal cell carcinoma. Pancreatology 9:392–397
Deguchi Y, Shimada K, Nara S, Esaki M, Sakamoto Y, Kosuge T, Hiraoka N (2009) Pancreaticojejunostomy with invagination of the punched pancreatic remnant after medial pancreatectomy and enucleation for multiple metastases of renal cell carcinoma: report of a case. Surg Today 39:1086–1090
Machado N, Chopra P (2009) Pancreatic metastasis from renal carcinoma managed by Whipple resection. A case report and literature review of metastatic pattern, surgical management and outcome. JOP 10:413–418
Aimoto T, Uchida E, Yamahatsu K, Yoshida H, Hiroi M, Tajiri T (2008) Surgical treatment for isolated multiple pancreatic metastases from renal cell carcinoma: report of a case. J Nippon Med Sch 75:221–224
Kawakami H, Kuwatani M, Yamato H, Shinada K, Hirano S, Kondo S, Yonemori A, Matsuno Y, Asaka M (2008) Pancreatic metastasis from renal cell carcinoma with intraportal tumor thrombus. Inter Med 47:1967–1970
Koide N, Yokoyama Y, Oda K, Nishio H, Ebata T, Abe T, Igami T, Nimura Y, Nagino M (2008) Pancreatic metastasis from renal cell carcinoma: results of the surgical management and pathologic findings. Pancreas 37:104–107
Varker K, Muscarella P, Wall K, Ellison CH, Bloomston M (2007) Pancreatectomy for non-pancreatic malignancies results in improved survival after R0 resection. World J Surg Oncol 5:145–151
Zerbi A, Ortolano E, Balzano G, Borri A, Beneduce A, Di Carlo V (2008) Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection? Ann Surg Oncol 15:1161–1168
Tuech J, Lefebure R, Bridoux V, Albouy B, Lermite E, Le Pessot F, Le Blanc-Louvry I, Michot F (2008) Combined resection of the pancreas and inferior vena cava for pancreatic metastasis from renal cell carcinoma. J Gastrointest Surg 12:612–615
Karimi K, McFadden D (2007) Pancreatic resection for metastatic renal cell carcinoma to the pancreas. Am Surg 73:1158–1160
Bahra M, Jacob D, Langrehr J, Glanemann M, Schumacher G, Lopez-Hänninen E, Neuhaus P (2008) Metastatic lesions to the pancreas. When is resection reasonable? Chirurgie 79:241–248
Maeda H, Okabayashi T, Nishimori I, Kobayashi M, Sugimoto T, Kohsaki T, Onishi S, Hanazaki K (2007) Duodenum-preserving pancreatic head resection for pancreatic metastasis from renal cell carcinoma: a case report. Langenbecks Arch Surg 392:649–652
Eidt S, Jergas M, Schmidt R, Siedek M (2007) Metastasis to the pancreas—an indication for pancreatic resection? Langenbecks Arch Surg 392:539–542
Crippa ST, Angelini C, Mussi CH, Bonardi C, Romano F, Sartori P, Uggeri F, Bovo G (2006) Surgical treatment of metastatic tumors to the pancreas: a single center experience and review of the literature. World J Surg 30:1536–1542
Köhler K, Haroske G, Ludwig K (2006) Management of pancreatic metastases from renal cell carcinoma. Report of five cases. Zentralbl Chir 131:425–428
Wente M, Kleeff J, Esposito I, Hartel M, Müller M, Fröhlich B, Büchler M, Friess H (2005) Renal cancer cell metastasis into the pancreas. A single-center experience and overview of the literature. Pancreas 30:218–222
Ninan S, Jain P, Paul A, Menon K (2005) Synchronous pancreatic metastases from asymptomatic renal cell carcinoma. JOP 6:26–28
Zacharoulis D, Asopa V, Karvounis E, Williamson R (2003) Resection of renal metastases to the pancreas: a surgical challenge. HPB 5:137–141
Thompson L, Heffess C (2000) Renal cell carcinoma to the pancreas in surgical pathology material. Cancer 89:1076–1088
Sweeney A, Wu M, Hilsenbeck S, Brunicardi CH, Fisher W (2009) Value of pancreatic resection for cancer metastatic to the pancreas. J Surg Res 156:189–198
Law C, Wei A, Hanna S, Al-Zahrani M, Taylor B, Greig P, Langer B, Gallinger ST (2003) Pancreatic resection for metastatic renal cell carcinoma: presentation, treatment and outcome. Ann Surg Oncol 10:922–926
Sohn T, Yeo C, Cameron Y, Nakeeb A, Lillemoe K (2001) Renal cell carcinoma metastatic to the pancreas: results of surgical management. J Gastrointest Surg 5:346–351
Sauvanet A, Barthes T, Levy PH, Flejou JF, Delcenserie R, Bernades P, Belghiti J (1993) Late pancreatic metastasis from renal cell carcinoma. Pancreas 8:742–744
Butturini G, Bassi C, Falconi M, Salvia R, Caldiron E, Iannucci A, Zamboni G, Graziani R, Procacci C, Pederzoli P (1998) Surgical treatment of pancreatic metastases from renal cell carcinomas. Dig Surg 15:241–246
Altschuler E, Ray A (1998) Spontaneous regression of a pancreatic metastasis of a renal cell carcinoma. Arch Fam Med 7:516–517
Bechade D, Palazzo I, Desrame J, Duvic C, Herody M, Didelot F, Coutant G, Algayres J (2002) Pancreatic metastasis of renal cell carcinoma: report of three cases. Rev Med Interne 23:862–866
Chou Y, Chiou H, Hong T, Tiu C, Chiou S, Su C, Tsay S (2002) Solitary metastasis from renal cell carcinoma presenting as diffuse pancreatic enlargement. J Clin Ultrasound 30:499–502
Gupta R, Lallu S, Delahunt B (1998) Fine-needle aspiration cytology of metastatic clear-cell renal carcinoma presenting as a solitary mass in the head of the pancreas. Diagn Cytopathol 19:194–197
Strijk SP (1989) Pancreatic metastases of renal cell carcinoma: report of two cases. Gastrointest Radiol 14:123–126
Py J, Arnaud J, Cinqualbre J, Adloff M, Bollack C (1984) Pancreatic metastasis from clear cell carcinoma of the kidney. Acta Chir Belg 84:117–121
Zhao B, Kimura W, Futakawa N, Muto T, Haida K (1997) Renal cell carcinoma of the spindle cell type with metastasis to the pancreas: a case report. Jpn J Clin Oncol 27:58–61
Ghavamian R, Klein K, Stephens D, Welch T, LeRoy A, Richardson R, Burch P, Zincke H (2000) Renal cell carcinoma metastatic to the pancreas: clinical and radiological features. Mayo Clin Proc 75:581–585
Rini B, Escudier B, Tomczak P, Kaprin A, Szczylik C, Hutson T, Michaelson D, Gorbunova V, Gore M, Rusakov I, Negrier S, Ou Y, Castellano D, Lim H, Uemura H, Tarazi J, Cella D, Chen D, Rosbrook B, Kim S, Motzer R (2012) Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomized phase III trial. Lancet 378:1931–1939
Beck J, Bellmunt J, Escudier B (2011) Long-term stable disease in metastatic renal cell carcinoma: sorafenib sequenced to sunitinib and everolimus: a case study. Med Oncol 28:1379–1383
Medioni J, Choueiri T, Zinzindohoue F, Cho D, Fournier L, Oudart ST (2009) Response of renal cell carcinoma pancreatic metastasis to sunitinib treatment: a retrospective analysis. J Urol 181:2470–2475
Ballarin R, Spaggiari M, Cautero N, De Ruvo N, Montalti R, Longo C, Pecchi A, Giacobazzi P, De Marco G, D’Amico G, Gerunda G, Di Benedetto F (2011) Pancreatic metastases from renal cell carcinoma: the state of the art. World J Gastroenterol 17:4747–4756
Le Borgne J, Partensky C, Glemain P, Dupas B, de Kerviller B (2000) Pancreaticoduodenectomy for metastatic ampullary and pancreatic tumors. Hepatogastroenterology 47:540–544
Kassabian A, Stein J, Jabbour N, Parsa K, Skinner B, Parekh D, Cosenza C, Selby R (2000) Renal cell carcinoma metastatic to the pancreas: a single institution series and review of the literature. Urology 56:211–215
Yavascaoglu I, Korun N, Oktay B, Simsek U, Ozyurt M (1999) Renal cell carcinoma with solitary synchronous pancreaticoduodenal and metachronous periprostatic metastases: report of a case. Surg Today 29:364–366
Hashimoto M, Miura Y, Matsuda M, Watanabe G (2001) Concomitant duodenal and pancreatic metastases from renal cell carcinoma: report of a case. Surg Today 31:180–183
Hirota T, Tomida T, Iwasa M, Takahashi K, Kaneda M, Tamaki H (1996) Solitary pancreatic metastasis occurring 8 years after nephrectomy for renal cell carcinoma. A case report and surgical review. Int J Pancreatol 19:145–153
Faure JP, Tuech J, Richer J, Pessaux P, Arnaud J, Carretier M (2001) Pancreatic metastasis of renal cell carcinoma: presentation, treatment and survival. J Urol 165:20–22
Fabre J, Rouanet P, Dagues F, Blanc F, Baumel H, Domergue J (1995) Various features and surgical approach of solitary pancreatic metastasis from renal cell carcinoma. Eur J Surg Oncol 21:683–686
Loré J, Madden J, Gerold F (1958) Pre-existing portocaval shunts: a hypothesis for the bizarre metastases of some carcinomas. Cancer 11:24–27
Saitoh H, Yoshida K, Uchijima Y, Kobayashi N, Suwata J, Nakame Y (1991) Possible metastatic routes via portocaval shunts in renal adenocarcinoma with liver metastasis. Urology 37:598–601
Allen-Mersh T (1982) Significance of the site of origin of pancreatic exocrine adenocarcinoma. J Clin Pathol 35:544–546
Fricke P, Schulz H, Buhtz P, Lippert H (2000) The pancreas as a site of multiple metastases from renal cell carcinoma. Report of one case and review of the literature. Chirurg 71:575–579
Merkle E, Boaz T, Kolokythas O, Haaga J, Lewin J, Brambs H (1998) Metastases to the pancreas. Br J Radiol 71:1208–1214
Marcote-Valdivieso E, Arlandis F, Baltasar A, Martinez C, Vierna G (1993) Synchronous pancreatic metastasis of renal carcinoma. Rev Esp Enferm Dig 83:471–473
Oka H, Hatayama T, Taki Y, Ueyama H, Hida S, Noguchi M (1991) A resected case of renal cell carcinoma with metastasis to the pancreas. Hinyokika Kiyo 37:1531–1534
Mehta N, Volpe C, Haley T, Balos L, Bradley E, Doerr R (2000) Pancreaticoduodenectomy for metastatic renal cell carcinoma. Surg Today 30:94–97
The Cancer Genome Atlas Research Network (2013) Comprehensive molecular characterization of clear cell renal carcinoma. Nature 499:43–49
Gerlinger M, Rowan A, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald N, Butler A, Jones D, Raine K, Latimer C, Santos C, Nohadani M, Eklund A, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal A, Swanton C (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892
Bartel D (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
Marta G, Garicochea B, Carvalho A, Real J, Kowalski L (2015) MicroRNA, cancer and ionizing radiation: where we are? Rev Assoc Med Bras 61:275–281
Hammond S (2015) An overview of microRNAs. Adv Drug Deliv Rev 87:3–14
Chan S, Wang L (2015) Regulation of cancer metastasis by microRNAs. J Biomed Sci 22:9
Chen D, Li Y, Su Z, Yu Z, Yu W, Li Y, Giu Y, Yang S, Lai Y (2015) Identification of miR125a5p as a tumor suppressor of renal cell carcinoma, regulating cellular proliferation, migration and apoptosis. Mol Med Rep 11:1278–1283
Zhang X, Xu G, Zhou Y, Yan J (2018) MicroRNA-183 promotes the proliferation and metastasis of renal cell carcinoma through targeting Dickkopf-related protein 3. Oncol Lett 15:6003–6008
Nicoloso M, Spizzo R, Shimizu M, Rossi S, Calin G (2009) Micro-RNAs: the micro steering wheel of tumour metastases. Nat Rev Cancer 9:293–302
Ding X (2014) MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT). Chin J Cancer 33:140–146
Yamasaki T, Seki N, Yoshino H, Itesako T, Hidaka H, Yamada Y, Tatarano S, Yonezawa T, Kinoshita T, Nakagawa M, Enokida H (2013) MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway. J Urol 190:1059–1068
Su Z, Chen D, Zhang E, Li Y, Yu Z, Shi M, Jiang Z, Ni L, Yang S, Gui Y, Ye J, Lai Y (2015) MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma. Mol Med Rep 12:1535–1543
Li Y, Chen D, Su Z, Li Y, Liu J, Jin L, Shi M, Jiang Z, Qi Z, Gui Y, Yang S, Mao X, Wu X, Lai Y (2016) MicroRNA106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis. Mol Med Rep 13:1420–1426
Sceneay J, Smyth M, Möller A (2013) The pre-metastatic niche: finding common ground. Cancer Metastasis Rev 32:449–464
Liu Y, Cao X (2016) Characteristics and significance of the pre-metastatic niche. Cancer Cell 30:668–681
Grange C, Tapparo M, Collino F, Vitillo L, Damasco C, Deregibus M, Tetta C, Bussolati B, Camussi G (2011) Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 71:5346–5356
Liu S, Jiang M, Zhao Q, Li S, Peng Y, Zhang P, Han M (2014) Vascular endothelial growth factor plays a critical role in the formation of the pre-metastatic niche via prostaglandin E2. Oncol Rep 32:2477–2484
Wang H, Yu C, Gao X, Welte T, Muscarella A, Tian L, Zhao H, Zhao Z, Du S, Tao J, Lee B, Westbrook T, Wong ST, Rosen I, Osborne K, Zhang X (2015) The osteogenetic niche promotes early-stage bone colonization of disseminated breast cancer cells. Cancer Cell 27:193–210
Wang Y, Sun Y, Li D, Zhang L, Wang K, Zuo Y, Gartner T, Liu J (2013) Platelet P2Y12 is involved in murine pulmonary metastasis. PLoS ONE 8:e80780
Chu G, Zhau H, Wang R, Rogatko A, Feng X, Zayzafoon M, Liu Y, Farach-Carson M, You S, Kim J, Freeman M, Chung L (2014) RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization. Endocr Relat Cancer 21:311–326
Walenkamp A, Lapa C, Herrmann K, Wester HJ (2017) CXCR4 ligands: the next big hit? J Nucl Med 58:77S-82S
Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan M, McClanahan T, Murphy E, Yuan W, Wagner ST, Barrera J, Mohar A, Verastegul E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56
Price J, Naito S, Fidler I (1988) Growth in an organ microenvironment as a selective process in metastasis. Clin Exp Metastasis 6:91–102
Waghorne C, Thomas M, Lagarde A, Kerbel R, Breitman M (1988) Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations. Cancer Res 48:6109–6114
Wang K, Li J, Li S, Bolund L, Wiuf C (2009) Estimation of tumor heterogeneity using CGH array data. BMC Bioinform 10:12
Bissig H, Richter J, Desper R, Meier V, Schraml P, Schäffer AA, Sauter G, Mihatsch MJ, Moch H (1999) Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization. Am J Pathol 155:267–274
Fidler I, Kripke M (1977) Metastasis results from preexisting variant cells within a malignant tumor. Science 197:893–895
Raz A, Hanna N, Fidler I (1981) In vivo isolation of a metastatic tumor cell variant involving selective and nonadaptive processes. J Natl Cancer Inst 66:183–189
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Sellner, F. Isolated pancreatic metastases from renal cell carcinoma: an outcome of a special metastatic pathway or of specific tumor cell selection?. Clin Exp Metastasis 35, 91–102 (2018). https://doi.org/10.1007/s10585-018-9910-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10585-018-9910-1